首頁 > 市場調查報告書 > 製藥

生物製劑基因治療學和RNAi

市場調查報告書

商品編碼

2148371

基因遞送平台市場：按遞送平台、載體類型、應用、最終用戶和地區分類

Gene Delivery Platform Market, By Delivery Platform, By Vector Type, By Application, By End User, By Geography

出版日期: 2026年09月30日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

基因遞送平台市場預計到 2026 年將達到 87.4 億美元，到 2033 年將達到 245.2 億美元。預計從 2026 年到 2033 年，該市場將以 15.9% 的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	87.4億美元
歷史數據時期：	2020-2024	預測期：	2026-2033
2026年至2033年預測期間的複合年成長率：	15.90%	2033年市場規模預測：	245.2億美元

基因遞送平台是分子醫學的基礎組成部分，用於將遺傳物質遞送至目標位點，以達到治療、預防和研究的目的。本產業涵蓋病毒載體平台（如腺相關病毒、慢病毒和腺病毒載體）以及非病毒載體系統（如脂質奈米顆粒、聚合物載體和電穿孔），應用於基因治療、基因修飾、mRNA遞送和細胞治療等領域。

全球基因遞送平台市場的發展主要得益於標靶遞送、基於 CRISPR 的療法、新一代非病毒載體系統以及基因藥物臨床應用的不斷拓展。儘管腺相關病毒 (AAV) 仍是一種成熟的遞送平台，但對脂質奈米顆粒 (LNP) 和其他非病毒技術的日益關注正在拓展可遞送物質的範圍、標靶化能力和重複給藥的可能性。

市場動態

全球基因遞送平台市場的發展主要受基因治療和細胞治療產品線擴張、遺傳疾病發病率上升以及腺相關病毒（AAV）、慢病毒和非病毒遞送技術的創新所驅動。基因組編輯療法的應用範圍不斷擴大，載體工程技術的進步進一步拓展了遞送平台的應用領域，而管理體制的變化也促進了相關技術的研發和商業化。

然而，基因遞送平台市場的成長受到許多因素的限制，例如高昂的研發和生產成本、載體的免疫抗原性、有效載荷能力以及難以實現可重複的大規模生產。儘管如此，在精準遞送技術的不斷進步的支持下，體內基因組編輯遞送、組織靶向脂質奈米顆粒（LNP）、新一代病毒載體以及針對神經系統疾病和其他標靶化疾病的遞送系統等領域仍存在著巨大的發展機會。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球基因遞送平台市場主要公司的概況：公司亮點、產品系列、關鍵亮點、財務表現和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
本市場報告面向該產業的各類相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用全球基因遞送平台市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Pfizer Inc.
Becton, Dickinson and Company
Thermo Fisher Scientific Inc.
Merck KGaA
Lonza Group Ltd.
Catalent, Inc.
Oxford Biomedica plc
Takara Bio Inc.
Charles River Laboratories International, Inc.
Danaher Corporation

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10175

Gene Delivery Platform Market is estimated to be valued at USD 8.74 Bn in 2026 and is expected to reach USD 24.52 Bn by 2033, growing at a compound annual growth rate (CAGR) of 15.9% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 8.74 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	15.90%	2033 Value Projection:	USD 24.52 Bn

Gene delivery platforms are a foundational component of molecular medicine and are used for the targeted delivery of genetic material for therapeutic, prophylactic and research purposes. The industry includes viral platforms like AAV, lentiviral and adenoviral vectors, and non-viral systems including lipid nanoparticles, polymeric carriers and electroporation, for gene therapy, gene modification, mRNA delivery and cell therapy applications.

The global gene delivery platform market is driven by advances in targeted delivery, CRISPR-based therapies and next generation non-viral systems, as well as the growing clinical translation of genetic medicines. While AAV remains an established delivery platform, increasing focus on LNPs and other non-viral technologies is expanding the range of payloads, targeting capabilities and potential for repeat administration.

Market Dynamics

The global gene delivery platform market is driven by the growing pipeline of gene and cell therapies, increasing incidence of genetic diseases, and innovations in AAV, lentiviral, and non-viral delivery technologies. Genome-editing therapies' expanding applications and improvements in vector engineering are further broadening delivery applications, while the development and commercialization are also supported by changing regulatory structures.

However, the growth of gene delivery platform market is limited by factors such as high development and manufacturing costs, vector immunogenicity, payload capacity and difficulty in achieving reproducible large-scale production. Nevertheless, significant opportunities exist within in vivo genome-editing delivery, tissue-targeted LNPs, next-generation viral vectors and delivery systems for neurological and other hard-to-target diseases, supported by ongoing advances in precision delivery technologies.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global gene delivery platform market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Pfizer Inc., Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Merck KGaA, Lonza Group Ltd., Catalent, Inc., Oxford Biomedica plc, Takara Bio Inc., Charles River Laboratories International, Inc., and Danaher Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global gene delivery platform market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global gene delivery platform market

Market Segmentation

Delivery Platform Insights (Revenue, USD Bn, 2021 - 2033)
- Viral Delivery Platforms
- Non-Viral Delivery Platforms
Vector Type Insights (Revenue, USD Bn, 2021 - 2033)
- Adeno-Associated Virus (AAV)
- Adenovirus
- Lentivirus
- Other Viral Vectors
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Gene Therapy
- Cell Therapy
- Vaccines
- Research
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutions
- Hospitals and Specialized Treatment Centers
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Pfizer Inc.
- Becton, Dickinson and Company
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Lonza Group Ltd.
- Catalent, Inc.
- Oxford Biomedica plc
- Takara Bio Inc.
- Charles River Laboratories International, Inc.
- Danaher Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Gene Delivery Platform Market, By Delivery Platform
- Global Gene Delivery Platform Market, By Vector Type
- Global Gene Delivery Platform Market, By Application
- Global Gene Delivery Platform Market, By End User
- Global Gene Delivery Platform Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Delivery Platform Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Gene Delivery Platform Market, By Delivery Platform, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Viral Delivery Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Non-Viral Delivery Platforms
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Gene Delivery Platform Market, By Vector Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Adeno-Associated Virus (AAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Adenovirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Lentivirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Other Viral Vectors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Gene Delivery Platform Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Gene Delivery Platform Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Hospitals and Specialized Treatment Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Gene Delivery Platform Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Delivery Platform, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Pfizer Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Becton, Dickinson and Company
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck KGaA
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Lonza Group Ltd.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Catalent, Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Biomedica plc
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Takara Bio Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories International, Inc.
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies
Danaher Corporation
- Company Highlights
- Delivery Platform Portfolio
- Key Developments
- Financial Performance
- Strategies